01 Adoption of Closed-Incision Negative Pressure Wound Therapy The surgical site infection control market analysis indicates increasing adoption of closed-incision negative pressure wound therapy for patients at higher risk of surgical complications. These systems help manage wound fluid and protect surgical incisions during recovery. Hospitals are assessing their use in orthopedic, cardiovascular, and abdominal surgeries. Clinical guidance supports selective use rather than routine application, strengthening demand for specialized postoperative wound management solutions.
02 Focus on Preoperative Patient Decolonization Hospitals are strengthening preoperative infection prevention practices through targeted patient decolonization. This approach focuses on reducing bacterial contamination before surgical procedures, particularly among patients at risk of Staphylococcus aureus infections. NICE recommends considering nasal mupirocin alongside chlorhexidine body washing for procedures where Staphylococcus aureus presents a significant infection risk.
01 Supply chain disruptions are expected to have a moderate impact on the surgical site infection control market share due to shortages of sterile dressings, antiseptics, surgical drapes, and medical-grade materials. The market is expected to experience a K-shaped recovery, as established manufacturers can maintain supplies through diversified sourcing. Smaller suppliers may face higher production costs and procurement delays. The market is projected to grow at a CAGR of 4.79%. Under an illustrative disruption scenario, growth could decline by approximately 1.0 percentage point to 3.79% in the short term. Improved material availability and stable distribution networks could restore growth to 4.79%.
01 The surgical site infection control market forecasts strategic investments in advanced wound care products, sterile surgical supplies, and manufacturing capacity expansion.
02 Key Investment and Funding Activities in Surgical Site Infection Control Market, 2025 Company Value (USD) Details Mölnlycke Health Care USD 135 Million In September 2025, Mölnlycke began expanding its wound care manufacturing facility in Maine, USA, to increase production capacity. Mölnlycke Health Care USD 400 Million In June 2025, Mölnlycke secured financing from the Swedish Export Credit Corporation to support global expansion and development.
01 Preference for Antimicrobial-Coated Surgical Sutures and Increasing Adoption of Standardized Surgical Infection Prevention Protocols Drives Market Adoption of antimicrobial-coated sutures is strengthening demand for specialized surgical infection prevention products. These sutures contain antibacterial agents that help limit bacterial colonization around surgical incisions. For example, Johnson & Johnson's ETHICON offers triclosan-coated VICRYL Plus and MONOCRYL Plus sutures for surgical wound closure. Their availability across different suture materials supports wider application in surgical procedures. Hospitals are increasingly considering antimicrobial sutures as part of standardized infection prevention protocols.Standardized surgical infection prevention protocols lead to higher demand for sterile surgical drapes and preoperative skin antiseptics. Hospitals are adopting standardized infection prevention practices to maintain consistent surgical safety standards. WHO guidelines recommend alcohol-based chlorhexidine solutions for surgical site skin preparation in appropriate procedures. These recommendations support the use of specialized antiseptic products and encourage healthcare facilities to maintain consistent procurement of surgical infection control supplies.
01 High Cost of Advanced Surgical Wound Management Products and Limited Clinical Suitability of Advanced Negative Pressure Wound Therapy Restrains Market Expansion The high cost of specialized surgical infection prevention products limits adoption among hospitals with restricted purchasing budgets. Advanced negative pressure wound therapy systems require additional equipment and disposable components compared with standard dressings. These expenses can make routine use difficult in cost-sensitive healthcare facilities.The selective use of closed-incision negative pressure wound therapy limits its adoption across routine surgical procedures. These systems are primarily considered for patients at higher risk of wound complications rather than all surgical patients. Their application also requires appropriate wound assessment and careful patient selection.
01 Integration of Fluorescence Imaging Technology in Surgical Wound Assessment and Development of Sensor-Integrated Smart Wound Dressings Creates New Market Opportunities Integration of fluorescence imaging technology presents opportunities for manufacturers to develop advanced surgical wound monitoring solutions. This technology helps clinicians identify areas of elevated bacterial burden that may remain undetected during routine visual assessment. For example, MolecuLight's i:X imaging device uses fluorescence to visualize bacterial presence in wounds without requiring contrast agents. Its potential application in postoperative wound assessment creates opportunities for specialized infection detection and monitoring solutions.Advancements in sensor-integrated wound dressings are creating opportunities for manufacturers to develop products that monitor surgical incision conditions. These dressings can incorporate sensors to measure wound temperature and moisture levels, helping clinicians identify changes requiring further assessment. Their potential application in postoperative monitoring could reduce unnecessary dressing removal and support timely clinical intervention.